Therefore, TREM-1-expressing macrophages acquire an aberrant phenotype in IBD, and in vitro engagement of TREM-1 with a cross-linking antibody resulted in enhanced production of TNF-α, IL-6, IL-8, and monocyte chemotactic protein (MCP)-1 (Figure 3A) [32]. This evidence concerns the gene TREM1 and inflammatory bowel disease.